193 related articles for article (PubMed ID: 22156764)
1. Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis.
Chen KC; Yang YK; Howes O; Lee IH; Landau S; Yeh TL; Chiu NT; Chen PS; Lu RB; David AS; Bramon E
Schizophr Bull; 2013 Mar; 39(2):378-86. PubMed ID: 22156764
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients.
Schmitt GJ; Frodl T; Dresel S; la Fougère C; Bottlender R; Koutsouleris N; Hahn K; Möller HJ; Meisenzahl EM
Eur Arch Psychiatry Clin Neurosci; 2006 Mar; 256(2):115-21. PubMed ID: 16284713
[TBL] [Abstract][Full Text] [Related]
3. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.
Silva N; Szobot CM; Shih MC; Hoexter MQ; Anselmi CE; Pechansky F; Bressan RA; Rohde LA
Clin Nucl Med; 2014 Feb; 39(2):e129-34. PubMed ID: 23856832
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Tourette's syndrome by (99m)Tc-TRODAT-1 SPECT/CT imaging.
Liu H; Dong F; Meng Z; Zhang B; Tan J; Wang Y
Ann Nucl Med; 2010 Aug; 24(7):515-21. PubMed ID: 20544324
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship between cumulative mercury exposure index and specific uptake ratio in the striatum on Tc-99m TRODAT SPECT.
Lin CY; Liou SH; Hsiech CM; Ku MC; Tsai SY
Clin Nucl Med; 2011 Aug; 36(8):689-93. PubMed ID: 21716022
[TBL] [Abstract][Full Text] [Related]
6. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
[TBL] [Abstract][Full Text] [Related]
7. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S
J Psychopharmacol; 2005 Sep; 19(5):488-93. PubMed ID: 16166186
[TBL] [Abstract][Full Text] [Related]
8. Greater striatal dopamine transporter density may be associated with major depressive episode.
Amsterdam JD; Newberg AB; Soeller I; Shults J
J Affect Disord; 2012 Dec; 141(2-3):425-31. PubMed ID: 22482744
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.
Hsiao MC; Lin KJ; Liu CY; Tzen KY; Yen TC
Schizophr Res; 2003 Dec; 65(1):39-46. PubMed ID: 14623373
[TBL] [Abstract][Full Text] [Related]
11. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study.
Chen PS; Yang YK; Yeh TL; Lee IH; Yao WJ; Chiu NT; Lu RB
Neuroimage; 2008 Mar; 40(1):275-9. PubMed ID: 18096411
[TBL] [Abstract][Full Text] [Related]
12. P300 waveform and dopamine transporter availability: a controlled EEG and SPECT study in medication-naive patients with schizophrenia and a meta-analysis.
Chen KC; Lee IH; Yang YK; Landau S; Chang WH; Chen PS; Lu RB; David AS; Bramon E
Psychol Med; 2014 Jul; 44(10):2151-62. PubMed ID: 24238542
[TBL] [Abstract][Full Text] [Related]
13. Reduced striatal dopamine transporter density associated with working memory deficits in opioid-dependent male subjects: a SPECT study.
Liang CS; Ho PS; Yen CH; Yeh YW; Kuo SC; Huang CC; Chen CY; Shih MC; Ma KH; Huang SY
Addict Biol; 2016 Jan; 21(1):196-204. PubMed ID: 25439653
[TBL] [Abstract][Full Text] [Related]
14. Unaltered Dopamine Transporter Availability in Drug-Naive Patients With Schizophrenia After 6 Months of Antipsychotics Treatment: A Naturalistic Study.
Chang WH; Chen KC; Lee IH; Chi MH; Chen PS; Yao WJ; Chiu NT; Yang YK
J Clin Psychopharmacol; 2017 Feb; 37(1):21-26. PubMed ID: 28027110
[TBL] [Abstract][Full Text] [Related]
15. Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1.
Chang TT; Yeh TL; Chiu NT; Chen PS; Huang HY; Yang YK; Lee IH; Lu RB
Bipolar Disord; 2010 Feb; 12(1):102-6. PubMed ID: 20148872
[TBL] [Abstract][Full Text] [Related]
16. Early white matter injuries associated with dopamine transporter dysfunction in patients with acute CO intoxication: A diffusion kurtosis imaging and Tc-99m TRODAT-1 SPECT study.
Chou MC; Lai PH; Li JY
Eur Radiol; 2019 Mar; 29(3):1375-1383. PubMed ID: 30143836
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
[TBL] [Abstract][Full Text] [Related]
18. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
Krause J; la Fougere C; Krause KH; Ackenheil M; Dresel SH
Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):428-31. PubMed ID: 16091862
[TBL] [Abstract][Full Text] [Related]
19. Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1.
Hoexter MQ; Fadel G; Felício AC; Calzavara MB; Batista IR; Reis MA; Shih MC; Pitman RK; Andreoli SB; Mello MF; Mari JJ; Bressan RA
Psychopharmacology (Berl); 2012 Nov; 224(2):337-45. PubMed ID: 22700036
[TBL] [Abstract][Full Text] [Related]
20. Genetic imaging study with [Tc-
Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
